[Clinical testing of the preparations SPN 40150 and N 150].
D000328:Adult; D000368:Aged; D001835:Body Weight; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D005260:Female; D006025:Glycosaminoglycans / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000009:adverse effects / Q000627:therapeutic use*; D010919:Placebos
D004338:Drug Combinations; D006025:Glycosaminoglycans; D009539:Nicotinic Acids; D010919:Placebos
Klinische Erprobung der Präparate SPN 40150 und N 150.